ENTITY

Anthem Biosciences (1234D IN)

27
Analysis
Health Care • India

•02 Feb 2026 07:49

NIFTY MIDCAP150 Index Rebalance Preview: 15 Potential Changes in March

There could be 15 changes in March. Estimated one-way turnover is 9.8% and round-trip trade is INR 26.5bn. With over US$43bn tracking the index...

Logo
361 Views
Share
•13 Jan 2026 04:30

2025: A Review of Our Hits and Misses in the Indian Primary Market

​In 2025, Indian mainboard IPOs raised INR 1.83 trillion; this insight reviews our hits and misses in Indian Primary Market for companies with post...

Logo
216 Views
Share
bullish•Meesho
•31 Dec 2025 06:20

AMFI Stock Reclassification Preview (Dec 2025): New Listings and REIT Inclusion Drive Changes

36 stocks could see size reclassification in Jan. 12 new stocks could be added to Large and Mid-cap. REITs will be added to the AMFI classification...

Logo
668 Views
Share
bullish•Tata Capital
•20 Nov 2025 09:56

AMFI Stock Reclassification Preview (Dec 2025): New Listings Shaking Up the Rankings

We currently forecast 31 migrations for the AMFI December reclassification. Many IPOs could be added to Large/Mid cap. The forecast upward...

Logo
884 Views
Share
•22 Jul 2025 13:45

Prestige Hospitality Ventures Pre-IPO-Marriott-Heavy Portfolio with Other Operating Revenue Concerns

Prestige Hospitality Ventures is looking to raise about US$317m in its upcoming India IPO. In this note, we talk about the company’s historical...

Logo
722 Views
Share
x